New MS treatments target myelin repair, neuroprotection, and CNS-resident immune cells, offering hope for progressive forms of the disease. Bruton tyrosine kinase inhibitors (BTKis) like tolebrutinib ...
Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...
As recently as the ‘90s, when patients arrived with all the typical symptoms — memory loss, double vision, fatigue — neurologists often avoided confirming what they most suspected: that the patient ...
RED BANK, NJ / ACCESS Newswire / August 5, 2025 / Tharimmune, Inc. (NASDAQ:THAR), ("Tharimmune" or the "Company), a clinical-stage biotechnology company dedicated to developing innovative therapeutic ...
Please provide your email address to receive an email when new articles are posted on . The most common comorbidity for both subsets of the study population was obesity. Risk for infection-related ...
Accelerated Cure Project for Multiple Sclerosis (ACP), a national nonprofit dedicated to accelerating research and improving the lives of people affected by multiple sclerosis (MS), today announced ...
New research reveals a strong link between persistent brain inflammation and early brain shrinkage in children with MS. These ...
NEW BERN, N.C. (WNCT) — Over 1,200 cyclists rode in the Bike MS Historic New Bern ride this weekend to fundraise for The National MS Society. As of Sunday, the ride raised $1.4 million of the $1.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results